To this end, we overexpressed human mGBA1 variants and human mLRRK2 in the fly to provide support to the observations that carriers of both human GBA1 and LRRK2 mutations develop a milder form of PD compared to that manifested in carriers of GBA1 mutations. Here, LRRK2 is linked to Parkinson disease.